你即將離開本站

並前往https://www.b3cnewswire.com/202011182151/bioversys-announces-first-subjects-dosed-in-phase-1-clinical-trial-of-bv100.html

BioVersys Announces First Subjects Dosed in Phase 1 ...

BV100 is a potential breakthrough hospital antibiotic to treat serious infections caused by Carbapenem Resistant Acinetobacter baumannii (CRAB) ...

確定！ 回上一頁

查詢 「CRAB antibiotics」的人也找了：

  1. CRAB antibiotics
    2.
  2. carbapenem-resistant acinetobacter baumannii
    3.
  3. Carbapenem-resistant Acinetobacter baumannii treatment
    4.
  4. MDRAB treatment
    5.
  5. Acinetobacter baumannii antibiotics
    6.
  6. xdrab抗生素
    7.
  7. Acinetobacter baumannii treatment
    8.
  8. carbapenem-resistant acinetobacter baumannii中文
    9.